Campbell & Co Investment Adviser’s Altimmune ALT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-37,426	Closed	-$230K	–	1036
2024 Q3	$230K	Sell	37,426 -12,068	-24%	-$81.8K	0.02%	988
2024 Q2	$329K	Sell	49,494 -60,719	-55%	-$448K	0.03%	801
2024 Q1	$1.12M	Buy	+110,213	New	+$1.12M	0.1%	350
2022 Q4	–	Sell	-39,317	Closed	-$502K	–	753
2022 Q3	$502K	Buy	+39,317	New	+$580K	0.11%	312
2021 Q4	–	Sell	-23,300	Closed	-$264K	–	605
2021 Q3	$264K	Buy	+23,300	New	+$283K	0.09%	410

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Campbell & Co Investment Adviser's ALT Position: Q4 2024 in Review

Campbell & Co Investment Adviser sold out of Altimmune (ALT) in Q4 2024, closing a stake of 37,426 shares — an estimated $230K sold.

Campbell & Co Investment Adviser first reported a position in ALT in Q3 2021 and held it in 5 quarters. The position peaked at $1.12M in Q1 2024. 182 funds tracked by Wall St. Rank hold ALT as of Q4 2024.

Campbell & Co Investment Adviser reported no remaining Altimmune position as of Q4 2024 after selling out during the quarter.
Campbell & Co Investment Adviser sold 37,426 Altimmune shares in Q4 2024, an estimated $230K.
Campbell & Co Investment Adviser first reported a position in Altimmune in Q3 2021 and held it in 5 quarters.
Campbell & Co Investment Adviser's Altimmune position peaked at $1.12M in Q1 2024.
182 funds tracked by Wall St. Rank held Altimmune as of Q4 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2024, filed 10 Feb 2025.